Operative Therapie des Endometriumkarzinoms und mögliche Entwicklungen

Postmenopausenblutungen bei dickem Endometrium weisen auf ein Endometriumkarzinom hin. 20% der Endometriumkarzinome betreffen jedoch prämenopausale Frauen. Die Standardtherapie des Endometriumkarzinoms besteht in der kompletten Hysterektomie und bilateralen Salpingo-Ovarektomie, kann jedoch bei Wunsch nach Fertilitätserhalt in bestimmten Fällen verzögert werden. Zusätzlich geben tumorbiologische Faktoren Entscheidungshilfe für das OP-Management.

Kernaussagen

• Das Endometriumkarzinom stellt weltweit die vierthäufigste Krebserkrankung bei Frauen dar.

• Typisches Frühsymptom des Endometriumkarzinoms ist die postmenopausale Blutung.

• Aufgrund früher Diagnosestellung ist die Prognose im Vergleich zu anderen gynäkologischen Malignomen gut.

• Die operative Standardtherapie des Endometriumkarzinoms besteht in der kompletten Hysterektomie und bilateralen Salpingo-Ovarektomie.

• Die operative Therapie des Endometriumkarzinoms ist in den letzten Jahren von Ansätzen zur De-Eskalation der operativen Radikalität charakterisiert.

• Dabei ist vor allem die Lymphonodektomie im Fokus.

• Sie kann einerseits erhebliche postoperative Morbidität hervorrufen, beeinflusst andererseits aber die Stratifizierung der adjuvanten Therapie bislang maßgeblich.

• Die Einführung einer tumorbiologischen Klassifikation des Endometriumkarzinoms wird in Zukunft auch das operative Management beeinflussen.

Schlüsselwörter

Laparoskopie - Laparotomie - Hysterektomie - Abrasio - Fertilitätserhalt - Lymphknotenstatus - Ovarialkarzinom

Publikationsverlauf

Artikel online veröffentlicht:
08. Juni 2022

• Literatur

• 1 Clarke MA, Long BJ, Del Mar Morillo A. et al. Association of endometrial cancer risk with postmenopausal bleeding in women: A systematic review and meta-analysis. JAMA Intern Med 2018; 178: 1210-1222 DOI: 10.1001/jamainternmed.2018.2820. (PMID: 30083701)
• 2 Timmermans A, Opmeer BC, Khan AS. et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 2010; 116: 160-167 DOI: 10.1097/AOG.0b013e3181e3e7e8. (PMID: 20567183)
• 3 AWMF. S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom Version 1.0 – April 2018, AWMF-Registernummer 032/034-OL. 2018: 59-60
• 4 Gebauer G, Hafner A, Siebzehnrübl E. et al. Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 2001; 184: 59-63 DOI: 10.1067/mob.[phone]. (PMID: 11174480)
• 5 Takano M, Ochi H, Takei Y. et al. Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?. Br J Cancer 2013; 109: 1760-1765 DOI: 10.1038/bjc.2013.521. (PMID: 24002604)
• 6 AWMF. S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom Version 1.0 – April 2018, AWMF-Registernummer 032/034-OL. 2018: 104
• 7 Walker JL, Piedmonte MR, Spirtos NM. et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009; 27: 5331-5336
• 8 Zullo F, Falbo A, Palomba S. Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2012; 207: 94-100 DOI: 10.1016/j.ajog.2012.01.010. (PMID: 22340944)
• 9 Galaal K, Bryant A, Fisher AD. et al. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev 2012; (12) CD006655 DOI: 10.1002/14651858.CD006655.pub2. (PMID: 22972096)
• 10 Mäenpää MM, Nieminen K, Tomás EI. et al. Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial. Am J Obstet Gynecol 2016; 215: 588 DOI: 10.1016/j.ajog.2016.06.005. (PMID: 27288987)
• 11 Cusimano MC, Simpson AN, Dossa F. et al. Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications. Am J Obstet Gynecol 2019; 221: 410-428 DOI: 10.1016/j.ajog.2019.05.004. (PMID: 31082383)
• 12 Williams MG, Bandera EV, Demissie K. et al. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Obstet Gynecol 2009; 113: 783-789 DOI: 10.1097/AOG.0b013e31819c7bdf. (PMID: 19305320)
• 13 Horn LC, Schnurrbusch U, Bilek K. et al. Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 2004; 14: 348-353 DOI: 10.1111/j.1048-891x.2004.014220.x. (PMID: 15086736)
• 14 Lacey jr. JV, Chia VM. Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas 2009; 63: 39-44 DOI: 10.1016/j.maturitas.2009.02.005. (PMID: 19285814)
• 15 Duska LR, Garrett A, Rueda BR. et al. Endometrial cancer in women 40 years old or younger. Gynecol Oncol 2001; 83: 388-393 DOI: 10.1006/gyno.2001.6434. (PMID: 11606102)
• 16 Dogan A, Schultheis B, Rezniczek GA. et al. Synchronous endometrial and ovarian cancer in young women: Case report and review of the literature. Anticancer Res 2017; 37: 969-978 DOI: 10.21873/anticanres.11406. (PMID: 28314254)
• 17 AWMF. S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom Version 1.0 – April 2018, AWMF-Registernummer 032/034-OL. 2018: 112-113
• 18 Selman TJ, Mann CH, Zamora J. et al. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health 2008; 8: 8 DOI: 10.1186/1472-6874-8-8. (PMID: 18457596)
• 19 Chang MC, Chen JH, Liang JA. et al. 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Radiol 2012; 81: 3511-3517 DOI: 10.1016/j.ejrad.2012.01.024. (PMID: 22305013)
• 20 Kakhki VR, Shahriari S, Treglia G. et al. Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature. Int J Gynecol Cancer 2013; 23: 1536-1543 DOI: 10.1097/IGC.0000000000000003. (PMID: 24172090)
• 21 Kim HS, Suh DH, Kim MK. et al. Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis. Jpn J Clin Oncol 2012; 42: 405-412 DOI: 10.1093/jjco/hys019. (PMID: 22396619)
• 22 Todo Y, Kato H, Kaneuchi M. et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375: 1165-1172 DOI: 10.1016/S0140-6736(09)62002-X. (PMID: 20188410)
• 23 Todo Y, Yamamoto R, Minobe S. et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010; 119: 60 DOI: 10.1016/j.ygyno.2010.06.018. (PMID: 20638109)
• 24 Abu-Rustum NR, Alektiar K, Iasonos A. et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006; 103: 714-718 DOI: 10.1016/j.ygyno.2006.03.055. (PMID: 16740298)
• 25 Dowdy SC, Borah BJ, Bakkum-Gamez JN. et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 2012; 127: 5-10 DOI: 10.1016/j.ygyno.2012.06.035. (PMID: 22771890)
• 26 Mariani A, Dowdy SC, Cliby WA. et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-18 DOI: 10.1016/j.ygyno.2008.01.023. (PMID: 18304622)
• 27 Kang S, Yoo HJ, Hwang JH. et al. Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies. Gynecol Oncol 2011; 123: 522-527 DOI: 10.1016/j.ygyno.2011.08.034. (PMID: 21945553)
• 28 Khoury-Collado F, Glaser GE, Zivanovic O. et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?. Gynecol Oncol 2009; 115: 453-455 DOI: 10.1016/j.ygyno.2009.08.026. (PMID: 19767064)
• 29 Leitao jr. MM, Khoury-Collado F, Gardner G. et al. Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol 2013; 129: 38-41 DOI: 10.1016/j.ygyno.2013.01.002. (PMID: 23321065)
• 30 Rossi EC, Kowalski LD, Scalici J. et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017; 18: 384-392 DOI: 10.1016/S1470-2045(17)30068-2. (PMID: 28159465)
• 31 Zapardiel I, Alvarez J, Barahona M. et al. Utility of Intraoperative Fluorescence Imaging in Gynecologic Surgery: Systematic Review and Consensus Statement. Ann Surg Oncol 2021; 28: 3266 DOI: 10.1245/s10434-020-09222-x. (PMID: 33095359)
• 32 Rossi EC, Jackson A, Ivanova A. et al. Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection. Int J Gynecol Cancer 2013; 23: 1704 DOI: 10.1097/IGC.0b013e3182a616f6. (PMID: 24177256)
• 33 Nagar H, Wietek N, Goodall RJ. et al. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer. Cochrane Database Syst Rev 2021; (06) CD013021 DOI: 10.1002/14651858.CD013021.pub2. (PMID: 34106467)
• 34 Cabrera S, Bebia V, Franco-Camps S. et al. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer. Int J Gynecol Cancer 2020; 30: 311-317 DOI: 10.1136/ijgc-2019-000923. (PMID: 31992599)
• 35 Martinelli F, Ditto A, Bogani G. et al. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers. Int J Gynecol Cancer 2020; 30: 332-338 DOI: 10.1136/ijgc-2019-000930. (PMID: 31911536)
• 36 Kandoth C, Schultz N, Cherniack AD. Cancer Genome Atlas Research Network. et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013; 497: 67-73
• 37 Talhouk A, Hoang LN, McConechy MK. et al. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment. Gynecol Oncol 2016; 143: 46-53 DOI: 10.1016/j.ygyno.2016.07.090. (PMID: 27421752)